scholarly journals Transcatheter closure of congenital ventricular septal defects: results of the European Registry

2007 ◽  
Vol 28 (19) ◽  
pp. 2361-2368 ◽  
Author(s):  
M. Carminati ◽  
G. Butera ◽  
M. Chessa ◽  
J. De Giovanni ◽  
G. Fisher ◽  
...  

2017 ◽  
Vol 46 ◽  
pp. 45-49
Author(s):  
R. Sobhy ◽  
A El-Sisi ◽  
AM Fattouh ◽  
HM Agha ◽  
SA El-Saiedi ◽  
...  


1992 ◽  
Vol 1 (2) ◽  
pp. 72-77 ◽  
Author(s):  
Nancy D. Bridges ◽  
James E. Lock


2006 ◽  
Vol 47 (2) ◽  
pp. 319-325 ◽  
Author(s):  
Yun-Ching Fu ◽  
John Bass ◽  
Zahid Amin ◽  
Wolfgang Radtke ◽  
John P. Cheatham ◽  
...  


2017 ◽  
Vol 10 (21) ◽  
pp. 2227-2228 ◽  
Author(s):  
Ming-Tai Lin ◽  
Chun-An Chen ◽  
Jui-Yu Hsu ◽  
Hsin-Chia Lin ◽  
Shuenn-Nan Chiu ◽  
...  


2011 ◽  
Vol 77 (2) ◽  
pp. 252-259 ◽  
Author(s):  
Nageswara Rao Koneti ◽  
Raghava Raju Penumatsa ◽  
Vasudevan Kanchi ◽  
Srinivas Kumar Arramraj ◽  
Jaishankar S. ◽  
...  


2015 ◽  
Vol 86 (7) ◽  
pp. 1264-1270 ◽  
Author(s):  
Alexander C. Egbe ◽  
Joseph T. Poterucha ◽  
Charanjit S. Rihal ◽  
Nathaniel W. Taggart ◽  
Frank Cetta ◽  
...  


2004 ◽  
Vol 18 (6) ◽  
pp. 911-914 ◽  
Author(s):  
Yoko Fujii ◽  
Takuya Fukuda ◽  
Noboru Machida ◽  
Tsuyoshi Yamane ◽  
Yoshito Wakao


2018 ◽  
Vol 28 (4) ◽  
pp. 598-601 ◽  
Author(s):  
Sezen Atik-Ugan ◽  
Irfan Levent Saltik

AbstractPatent ductus arteriosus occluders are used for transcatheter closure of ventricular septal defects, as well as for closure of patent ductus arteriosus. The Occlutech Duct Occluder is a newly introduced device for transcatheter closure of patent ductus arteriosus. Here, we present a case in which the Occlutech Duct Occluder was successfully used on a patient for the closure of a perimembraneous ventricular septal defect.



2020 ◽  
Vol 30 (10) ◽  
pp. 1517-1520
Author(s):  
Raymond N. Haddad ◽  
Régis Gaudin ◽  
Damien Bonnet ◽  
Sophie Malekzadeh-Milani

AbstractThe hybrid perventricular approach for the closure of trabecular ventricular septal defects is an attractive treatment modality for small children. Worldwide experience has shown that procedure success is influenced by the defect anatomical accessibility, operators’ expertise, and device technical features. In May 2018, a new promising device, the KONAR-Multi-functional™ ventricular septal defect occluder (Lifetech, Shenzhen, China), obtained CE-marking for septal defect transcatheter closure after the first-in-man implantation in 2013. Herein, this is the first report of successful perventricular closure of ventricular septal defect using this new device in a child with significant co-morbidities.



Sign in / Sign up

Export Citation Format

Share Document